Report period | 2020 | 2021 | 2022 | 2023 | 2024 | Q1 25 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
TLRY:US | Tilray Brands | Common share | - | US88688T1007 | $1.93 |
Company name | Tilray Brands |
---|---|
Tags | #pharmacy |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325 |
Mailing address | 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 |
Website | ir.tilray.com |
Information disclosure | www.sec.gov |